 |
Injection grade Hyaluronic acid
Bouliga
391390
Sodium hyaluronate (CAS 9067-32-7), also known as hyaluronic acid, is a glycosaminoglycan naturally present in human connective tissues. The 2.0MDa molecular weight specification refers to a specific chain length that offers balanced viscoelastic properties, making it suitable for dermal filler applications where volume retention and structural support are required.
This product appears as white or off-white granules or powder, with no odor and hygroscopic characteristics. It swells to form a clear solution in water and is insoluble in ethanol, ether, and other organic solvents. The 2.0MDa molecular weight falls within the high molecular weight range, which provides longer residence time in tissues compared to lower molecular weight variants.
Parameter | Specification |
Product Name | Sodium Hyaluronate |
CAS Number | 9067-32-7 |
HS Code | 391390 |
Grade | Injectable Grade |
Molecular Weight | 2.0MDa |
Appearance | White or off-white granules/powder |
Odor | Odorless |
Solubility | Soluble in water; insoluble in ethanol and ether |
Packaging | 1g/vial, 100g/bottle |
Storage Temperature | 2-8°C |
The 2.0MDa hyaluronic acid is primarily used in the production of dermal fillers. These fillers are administered through injection to add volume to facial areas and reduce the appearance of fine lines and wrinkles by retaining moisture in the skin. The 2.0MDa molecular weight provides appropriate viscosity and elasticity for facial contouring and volume restoration applications.
This injectable grade hyaluronic acid is also used as a raw material for viscosupplementation products. These products are injected into joint spaces to lubricate and cushion the joints, supporting the management of osteoarthritis symptoms and improving joint mobility.
In ophthalmology, 2.0MDa hyaluronic acid serves as a viscoelastic agent in surgical procedures including cataract extraction and corneal transplantation. It helps maintain the shape of the anterior chamber and protects delicate eye tissues during surgery.
Bouliga injectable grade sodium hyaluronate is produced through a microbial fermentation process using non-animal origin raw materials. The production process follows these steps: strain selection and cultivation, fermentation to produce mucopolysaccharides, multi-step purification to remove impurities, precipitation and dehydration, controlled drying, and sterile packaging.
This non-animal source production method minimizes the risk of immune reactions and ensures consistent product quality across batches. Advanced purification techniques are employed to reduce protein and endotoxin levels to meet injectable grade requirements.
Bouliga offers customization services to meet the specific requirements of different commercial users. Available customization options include different packing densities and particle sizes, products with varying protein content levels, customized molecular weight segments, and flexible packaging solutions for different production scales. We support both small-scale sample orders for formulation testing and large-volume bulk orders for continuous production needs.
This product should be stored at a temperature between 2°C and 8°C in a dry, well-ventilated area, protected from direct sunlight.
No, Bouliga injectable grade sodium hyaluronate is produced through microbial fermentation using non-animal origin raw materials.
Standard packaging options include 1g per vial and 100g per bottle. Custom packaging sizes can be arranged upon request.
Yes, samples are available for commercial users to evaluate product performance in their specific formulations.
